Review Article
Cyclosporine: A Commentary on Brand versus Generic Formulation Exchange
Table 1
Cyclosporine development timeline.
| Date | Significant event |
| November 1983 | Sandimmune (cyclosporine) oral solution approval | March 1990 | Sandimmune (cyclosporine) capsule approval | July 1995 | Neoral capsules and solution approval (brand cyclosporine modified) | October 1998 | SangStat’s SangCya (generic cyclosporine modified) approval | January 2000 | Cyclosporine modified capsules (Sandoz) approval | May 2000 | Cyclosporine modified capsules (Gengraf, Abbott) | December 2000 | SangCya withdrawal | December 2000 | Cyclosporine modified capsules (Pliva) approval | December 2001 | Cyclosporine modified solution (Pliva) approval | May 2002 | Cyclosporine capsules (generic Sandimmune, Apotex) approval | September 2004 | Cyclosporine solution (generic Sandimmune, Morton Grove) approval | January 2005 | Cyclosporine modified solution (Novex) approval | March 2005 | Cyclosporine modified capsules and solution (Ivax) approval |
|
|